A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine whether zidovudine (AZT) in conjunction with bone marrow transplantation
prevents the reinfection of donor hematopoietic/lymphoid cells in patients with positive HTLV
III antibody and large cell/diffuse histiocytic lymphoma. Patients who are candidates will be
evaluated for HTLV III activity and drug levels.